Cargando…
Causal relationship between PCSK9 inhibitor and autoimmune diseases: a drug target Mendelian randomization study
BACKGROUND: In addition to decreasing the level of cholesterol, proprotein convertase subtilis kexin 9 (PCSK9) inhibitor has pleiotropic effects, including immune regulation. However, the impact of PCSK9 on autoimmune diseases is controversial. Therefore, we used drug target Mendelian randomization...
Autores principales: | Xie, Weijia, Li, Jiaxin, Du, Hao, Xia, Jian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10424393/ https://www.ncbi.nlm.nih.gov/pubmed/37580807 http://dx.doi.org/10.1186/s13075-023-03122-7 |
Ejemplares similares
-
Investigation of the causal relationship between ALS and autoimmune disorders: a Mendelian randomization study
por: Alipour, Paria, et al.
Publicado: (2022) -
The causal relationship between autoimmune diseases and osteoporosis: a study based on Mendelian randomization
por: Wu, Shaofeng, et al.
Publicado: (2023) -
Investigating the potential impact of PCSK9-inhibitors on mood disorders using eQTL-based Mendelian randomization
por: Aman, Alisha, et al.
Publicado: (2022) -
Genetic variations in HMGCR and PCSK9 and kidney function: a Mendelian randomization study
por: Park, Sehoon, et al.
Publicado: (2023) -
Causal Relationship Between Gut Microbiota and Autoimmune Diseases: A Two-Sample Mendelian Randomization Study
por: Xu, Qian, et al.
Publicado: (2022)